Clinical trials in Pasadena, CA

31 recruiting studies have a site in or near Pasadena, CA, California.

Top conditions here

All conditions

Showing 31 of 31 studies

RecruitingPhase 3NCT05980949

Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)

Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company

Anaheim, CA · Chino, CA · +145 more sites

RecruitingPhase 3NCT07391774

Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial

Sponsor: National Cancer Institute (NCI)

Auburn, CA · Berkeley, CA · Beverly Hills, CA · +200 more sites

RecruitingPhase 3NCT07181109

Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

Sponsor: Alnylam Pharmaceuticals

Beverly Hills, CA · Chula Vista, CA · Covina, CA · +270 more sites

RecruitingPhase 3NCT07028853

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

Sponsor: Pfizer

Alhambra, CA · Atascadero, CA · Beverly Hills, CA · +124 more sites

RecruitingPhase 3NCT07816367

A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

Sponsor: Kallyope Inc.

Canoga Park, CA · Chula Vista, CA · Fountain Valley, CA · +69 more sites

RecruitingPhase 3NCT06136559

A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)

Sponsor: Merck Sharp & Dohme LLC

Berkeley, CA · La Jolla, CA · Pasadena, CA · +46 more sites

RecruitingPhase 3NCT07116967

Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)

Sponsor: Bristol-Myers Squibb

Encinitas, CA · Encino, CA · Fountain Valley, CA · +119 more sites

RecruitingPhase not listedNCT07556159

A Study Evaluating Disease Characteristics and Outcomes in Participants With Asthma in Routine Clinical Practice

Sponsor: Sanofi

California City, CA · La Palma, CA · Los Angeles, CA · +60 more sites

RecruitingPhase 3NCT07011745

A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease

Sponsor: Bristol-Myers Squibb

Garden Grove, CA · Long Beach, CA · +39 more sites

RecruitingPhase 3NCT07276724

A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)

Sponsor: Generate Biomedicines

Northridge, CA · Pasadena, CA · Rancho Cucamonga, CA · +33 more sites

RecruitingPhase 3NCT07174310

A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease

Sponsor: Hoffmann-La Roche

Fullerton, CA · La Jolla, CA · Los Angeles, CA · +50 more sites

RecruitingPhase 3NCT07228832

Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer

Sponsor: Summit Therapeutics

Beverly Hills, CA · Cerritos, CA · +109 more sites

RecruitingPhase 3NCT06929806

Multi-center Trial of Ferric Derisomaltose Versus no Intravenous Iron in Iron-deficient Subjects With Symptomatic Chronic Heart Failure

Sponsor: Pharmacosmos A/S

Pasadena, CA

RecruitingPhase 3NCT06585787

A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company

Anaheim, CA · Chino, CA · Long Beach, CA · +99 more sites

RecruitingPhase 3NCT07207811

CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis

Sponsor: Novo Nordisk A/S

La Jolla, CA · Los Angeles, CA · +60 more sites

RecruitingNot applicableNCT05541406

Efficacy of a Multi-level School Intervention for LGBTQ Youth

Sponsor: Washington University School of Medicine

El Monte, CA · +20 more sites

RecruitingPhase 3NCT05879926

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Sponsor: NRG Oncology

Anaheim, CA · Antioch, CA · Arroyo Grande, CA · +1223 more sites

RecruitingPhase 3NCT06072612

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

Sponsor: BriaCell Therapeutics Corporation

Anaheim, CA · Bakersfield, CA · Beverly Hills, CA · +76 more sites

RecruitingPhase 3NCT05511363

A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-1)

Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company

Encino, CA · Irvine, CA · Orange, CA · +56 more sites

RecruitingPhase 3NCT04967989

Clarifying the Optimal Application of SLT Therapy Trial

Sponsor: University of Pittsburgh

Laguna Hills, CA · Pasadena, CA · Sacramento, CA · +25 more sites

RecruitingPhase 2NCT07750873

A Trial of CRD-4730 in HFrEF

Sponsor: Cardurion Pharmaceuticals, Inc.

Pasadena, CA · +1 more sites

RecruitingPhase 3NCT05812807

Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab

Sponsor: Alliance for Clinical Trials in Oncology

Arroyo Grande, CA · Berkeley, CA · +825 more sites

RecruitingPhase 2NCT07017673

Phase II Trial of Ivonescimab in Combination With Carboplatin + Docetaxel in Patients With Early-Stage Triple Negative Breast Cancer

Sponsor: Cedars-Sinai Medical Center

Los Angeles, CA · Pasadena, CA · +1 more sites

RecruitingPhase 2NCT05595499

Fisetin to Improve Physical Function in Stage I-III Breast Cancer Survivors

Sponsor: Jonsson Comprehensive Cancer Center

Alhambra, CA · Beverly Hills, CA · Burbank, CA · +4 more sites

RecruitingPhase 3NCT06592924

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

Sponsor: Canadian Cancer Trials Group

Anaheim, CA · Arroyo Grande, CA · Baldwin Park, CA · +371 more sites

RecruitingPhase not listedNCT06699056

AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor

Sponsor: Peerbridge Health, Inc

Orange, CA · Pasadena, CA · +6 more sites

RecruitingPhase 3NCT04852887

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Sponsor: NRG Oncology

Anaheim, CA · Antioch, CA · Arroyo Grande, CA · +809 more sites

RecruitingNot applicableNCT06569303

Filipino Family Health Initiative 1.0

Sponsor: Kaiser Permanente

Pasadena, CA

RecruitingPhase 3NCT05929768

Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer

Sponsor: SWOG Cancer Research Network

Anaheim, CA · Arroyo Grande, CA · +952 more sites

RecruitingNot applicableNCT05143697

Motivational Wellness Coaching to Reduce Childhood Obesity in Families and Kids

Sponsor: Kaiser Permanente

Pasadena, CA

RecruitingPhase 2 / Phase 3NCT03094429

An Adaptive Phase II/III, Two-Part, Double-Blind, Randomized, Placebo-controlled, Dose-Finding, Multi-center Study of the Safety and Efficacy of NaBen®, as an Add-on Therapy With Clozapine, for Residual Symptoms of Refractory Schizophrenia in Adults

Sponsor: SyneuRx International (Taiwan) Corp

Pasadena, CA

Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.